Boston, MA 09/22/2014 (wallstreetpr) – According to a report published in Yahoo! Finance, recently, Covidien plc (NYSE:COV) declared the broadening of its Sonicision Cordless Ultrasonic Dissection Device portfolio. The strategy follows the approval granted by the U.S. Food and Drug Administration (FDA) for three more device lengths namely 13cm, 26cm and 48 cm.
The Sonicision system:
It has been reported that the company’s Sonicision design is a pistol-grip styled, hand-held, battery-supported surgical ultrasonic equipment. It has been designed to address hemostasis and soft-tissue incision. Also, the device has an array of applications including a full range of surgical processes. The procedures encompass bariatric, general, colorectal, urological and gynecological.
The recently-accepted device lengths also permit the surgeons to enhance their application of the Sonicision format. In fact, it encourages them to expand their use to a more diverse variety of surgical processes such as appendectomy, splenectomy and colectomy.
Increased mobility:
Also, the device’s cordless fashion enables total liberty of movement to the surgeons while applying the ultrasonic energy. The enhanced mobility, thereby, eradicates the necessity for controlling the cords in a sterile ground as well as facilitates in enhancing the procedural competencies. Further, lowering the numbers of cord as well as detached generators in the working chamber leads to a secured operating setting along with patient experience.
The Sonicision was unveiled in 2012:
Covidien plc (NYSE:COV), back in October, 2012, had disclosed Sonicision at the American College of Surgeons Clinical Congress. Sonicision is industry’s first such ultrasonic dissection device being designed. The full cordless ultrasonic portfolio is presently accessible in the U.S. Also, Covidien currently furnishes an extensive variety of alternatives for the surgeons while conducting urological, pediatric and even bariatric processes on patients of varying sizes.
Covidien now has the most multipurpose cordless ultrasonic portfolio in the market and is committed to designing and offering energy-dependant medical tools.
